Corcept Therapeutics
CORT
CORT
207 hedge funds and large institutions have $1.26B invested in Corcept Therapeutics in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 34 closing their positions.
Holders
207
Holders Change
-8
Holders Change %
-3.72%
% of All Funds
4.74%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
27
Increased
86
Reduced
64
Closed
34
Calls
$6.35M
Puts
$11.8M
Net Calls
-$5.47M
Net Calls Change
+$11.4M
Top Buyers
1 |
1
BlackRock
New York
|
$221M |
2 |
ISL
2
Ingalls & Snyder LLC
New York
|
$118M |
3 |
3
Invesco
Atlanta,
Georgia
|
$39M |
4 |
4
Morgan Stanley
New York
|
$25.7M |
5 |
5
Stifel Financial
St. Louis,
Missouri
|
$6.85M |